Surmodics announces agreement with Genentech/Roche to combine proprietary drug delivery system with Lucentis (ranibizumab) for the treatment of wet macular degeneration.
Small study shows long-lasting effects of intravitreal steroids for the treatment of diabetic macular edeam, a common complication of diabetic retinopathy.
Alimera's Iluvien proving effective in phase 3 clinical trials. Iluvien will release fluocinolone acetonide for the treatment of diabetic macular edema. Iluvien is an injectable extended release delivery system.
Evidence based medicine (EBM) gives us the proof that a new drug or treatment is valid and effective. The FDA provides a sound process by which treatments in the U.S. become evidence based.